Sagimet Biosciences Inc.
SGMT
$5.14
-$0.07-1.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.84M | 17.78M | 17.43M | 17.03M | 16.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.89M | 64.32M | 66.89M | 65.55M | 54.45M |
| Operating Income | -56.89M | -64.32M | -66.89M | -65.55M | -54.45M |
| Income Before Tax | -51.04M | -57.67M | -59.38M | -57.11M | -45.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.04 | -57.67 | -59.38 | -57.11 | -45.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.04M | -57.67M | -59.38M | -57.11M | -45.57M |
| EBIT | -56.89M | -64.32M | -66.89M | -65.55M | -54.45M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.58 | -1.79 | -1.85 | -1.78 | -1.44 |
| Normalized Basic EPS | -0.99 | -1.12 | -1.15 | -1.11 | -0.90 |
| EPS Diluted | -1.58 | -1.79 | -1.85 | -1.78 | -1.44 |
| Normalized Diluted EPS | -0.99 | -1.12 | -1.15 | -1.11 | -0.90 |
| Average Basic Shares Outstanding | 129.38M | 129.05M | 128.73M | 128.45M | 125.29M |
| Average Diluted Shares Outstanding | 129.38M | 129.05M | 128.73M | 128.45M | 125.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |